CoChat

Telomeres, Atherosclerosis, and Human Longevity: A Causal Hypothesis

Open access
Aviv, Abraham, Kark, Jeremy D., Susser, Ezra · 2015 · Epidemiology
Cited by 61

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Human telomere length, as expressed in leukocytes, is strongly fashioned by heritability.1–5 A number of genes that explain some of the inter-individual variation in leukocyte telomere length have already been identified.6–9 Leukocyte telomere length is longer in women than in men3,10,11 and in African Americans than in whites of European descent.12,13 In addition, offspring of older fathers display a longer leukocyte telomere length, a finding that may reflect longer telomeres in sperm of older men.14–17 In contrast to the male germline, telomeres in replicative somatic tissues, including the hematopoietic system, display age-dependent shortening. A shorter leukocyte telomere length is associated with aging-related diseases, principally atherosclerosis18,19 and reduced longevity.20,21 The prevailing interpretation is that a shorter leukocyte telomere length is the outcome of processes, mainly the age-dependent accruing burden of oxidative stress and inflammation22 that ultimately shorten the human lifespan. As such, leukocyte telomere length is considered to be a non-causal biomarker, ie, a telomeric “clock,” of human aging. We propose that telomere length is not only associated with atherosclerosis and longevity but is also a causal determinant of both. This hypothesis is based on a model of leukocyte telomere length dynamics (leukocyte telomere length and its attrition rate) that incorporates two key features. First, the model differentiates the findings of studies of telomere length dynamics in vitro from those in vivo. Second, the model distinguishes two phases of human leukocyte telomere length dynamics in vivo: growth and adulthood. THE TELOMERIC “CLOCK” BASED ON EXTRAPOLATIONS FROM IN VITRO STUDIES The metaphor of telomeres as a biological clock is based on research showing that somatic cell replication in culture causes telomere attrition, ultimately leading to replicative senescence (or apoptosis).23 Although senescence might be triggered by mechanisms other than critically short telomeres,24–26 the evidence is strong that the telomeric clock is a major factor in replicative senescence in vitro. Studies in cultured cells also revealed that oxidative stress heightens the loss of telomere repeats per replication, presumably due to the sensitivity of telomeres to oxidative stress.27 Leukocytes are the most frequently used somatic cells to study telomere biology in epidemiological settings. The traditional model of leukocyte telomere length dynamics, extrapolated from cultured cells to the in vivo state, is based on the premise that oxidative stress augments the loss of telomere repeats per replication of all somatic cells. However, in hematopoietic stem cells (HSCs) not only oxidative stress but also inflammation increases telomere shortening, because HSCs undergo more replication to replace leukocytes consumed by the inflammatory response. Shorter leukocyte telomere length, which reflects HSC telomere length,28,29 has therefore been attributed to a faster HSC telomere-length attrition due to a higher cumulative burden of oxidative stress and inflammation—two biological processes that are considered the hallmarks of atherosclerosis and aging.22 The concept of leukocyte telomere length as a biomarker of aging entails the premise that at birth, if not at conception, all individuals have a biological age—a telomeric clock time—of zero. In newborns, however, we see great variation in leukocyte telomere length, with values ranging from 8 to 11 kb or more.30,31 This variation among newborns exceeds the total average leukocyte telomere length shortening throughout the adult life course (20–90 years) estimated at <2.0 kb, assuming an average leukocyte telomere length attrition rate of 25–30 bp/year.32 Thus, the use of leukocyte telomere length as a biomarker of aging in vivo should account for not only leukocyte telomere length attrition but also leukocyte telomere length at birth for each individual, an important point often overlooked. TELOMERE DYNAMICS IN VIVO IN THE HEMATOPOIETIC SYSTEM Cultured cells typically display exponential proliferation, whereby one cell divides into two daughter cells, ie, symmetric replication. However, in vivo, HSCs experience both symmetric replication to two daughter HSCs and asymmetric replication to a daughter hematopoietic progenitor cell (HPC) and a daughter HSC.33 Symmetric replication, as in cultured cells, serves to expand exponentially the HSC reservoir during growth. It takes, for example, four cycles of symmetric HSC replication to generate 16 HSCs [2-4-8-16]. In contrast, asymmetric HSC replication during growth, which linearly expands the HPC pool and ultimately the peripheral blood cell mass, takes 16 cycles to generate 16 HPCs. Therefore, during growth, expansion of the HPC pool in tandem with the growing soma requires far more replication and more telomere attrition than the expansion of the HSC reservoir.29,34 Accordingly, the expansion of the HPC pool is pro

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/ede.0000000000000280

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 61

Metadata

Authors
Aviv, A., Kark, J. D., & Susser, E.
Venue
Epidemiology
Published
2015-05
Volume
26
Issue
3
Pages
295-299
ISSN
1044-3983 (ISSN-L)
OpenAlex
W2314849357
Cited by
61
References
16
FWCI
7.53
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Telomeres, Atherosclerosis, and Human Longevity: A Causal Hypothesis. https://app.cochat.ai/papers/10.1097/ede.0000000000000280
The paper
Aviv, A., Kark, J. D., & Susser, E. (2015). Telomeres, Atherosclerosis, and Human Longevity: A Causal Hypothesis. Epidemiology. https://doi.org/10.1097/ede.0000000000000280

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.